Hydrocortamate
 | |
| Systematic (IUPAC) name | |
|---|---|
|
[2-(11,17-dihydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15, 16-decahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl] 2-(diethylamino)acetate | |
| Clinical data | |
| Topical | |
| Pharmacokinetic data | |
| Excretion | Hepatic |
| Identifiers | |
| 76-47-1 | |
| PubChem | CID 408334 |
| DrugBank | DB00769 |
| ChemSpider | 361312 |
| UNII | Y3N00BK5WK |
| ChEBI | CHEBI:50851 |
| Synonyms | Hydrocortamate Hydrochloride, Magnacort, Ulcort |
| Chemical data | |
| Formula | C27H41NO6 |
| 475.61754 g/mol | |
|
SMILES
| |
| |
Hydrocortamate (Magnacort, Ulcortis) is a synthetic glucocorticoid with anti-inflammatory and immunosuppressive properties. It is used topically to treat inflammation due to corticosteroid-responsive dermatoses.[1]
References
| ||||||||||||||||||||